Predicted Trait | |
Reported Trait | Coronary artery disease |
Mapped Trait(s) | coronary artery disease (EFO_0001645) |
Additional Trait Information | UK Biobank codes: non-cancer codes: 1075; ICD9: 410, 4109, 412, 4129; ICD10: I21, I210-I214, I219, I21X, I22, I220, I221, I228, I229, I23, I230-I236, I238, I241, I252; OPCS4: K401-K404, K411-K414, K451-K455, K491, K492, K498, K499, K502, K751-K754, K758, K759 |
Score Construction | |
PGS Name | cad_1 |
Development Method | |
Name | LASSO |
Parameters | To reduce the number of candidate SNPs to a computationally feasible set, a gwas was performed on th... e raw phenotype and the 50,000 snps with smallest p-value were retained. The raw phenotype was regressed on age, sex, and the top 20 UK Biobank PCs and a residual phenotype was then built. The LASSO model was trained using these 50k SNPs and the adjusted phenotype.Show more |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 3,892 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000520 |
Citation (link to publication) | Raben TG et al. Sci Rep (2023) |
Ancestry Distribution | |
Score Development/Training | European: 100% 200,000 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
Phenotype Definitions & Methods
|
Age of Study Participants
|
Participant Follow-up Time
|
Additional Ancestry Description
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
— | [ ,
47.9 % Male samples | European | NR | UK Biobank codes: non-cancer codes: 1075; ICD9: 410, 4109, 412, 4129; ICD10: I21, I210-I214, I219, I... 21X, I22, I220, I221, I228, I229, I23, I230-I236, I238, I241, I252; OPCS4: K401-K404, K411-K414, K451-K455, K491, K492, K498, K499, K502, K751-K754, K758, K759Show more | — | used UK self report 'white' category and then used an adjusted phenotype that includes a regression on the top 20 PCs | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source
|
Trait
|
PGS Effect Sizes (per SD change) |
Classification Metrics
|
Other Metrics
|
Covariates Included in the Model
|
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM020130 | PSS011296| European Ancestry| 45,334 individuals | PGP000520 | Raben TG et al. Sci Rep (2023) | Reported Trait: Coronary artery disease | — | AUROC: 0.74561 | — | year of birth, sex | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods
|
Participant Follow-up Time
|
Sample Numbers
|
Age of Study Participants
|
Sample Ancestry
|
Additional Ancestry Description
|
Cohort(s)
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
PSS011296 | 22,667 sibling pairs | — | 45,334 individuals | — | European | — | UKB | — |